SeaStar Medical Holding Corporation
ICU • NASDAQ
SeaStar Medical Holding Corporation is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Eric Schlorff, with a market cap of $10.4M.
CEOEric Schlorff
Next Earnings
Upcoming earnings announcement for SeaStar Medical Holding Corporation
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.92
Revenue Estimate
$375.0K
Earnings History
Past 12 earnings reports for SeaStar Medical Holding Corporation
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 25, 2026 | Q4 2025 | -$0.80Est: -$1.00 | +20.0% | $420.0KEst: $423.5K | -0.8% | — |
| Nov 13, 2025 | Q3 2025 | -$0.13Est: -$0.15 | +13.3% | $183.0KEst: $250.0K | -26.8% |  10-Q |
| Aug 13, 2025 | Q2 2025 | -$0.18 | — | $338.0KEst: $200.0K | +69.0% | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.44 | — | $293.0KEst: $150.0K | +95.3% | 10-Q |
| Mar 27, 2025 | Q4 2024 | -$0.90Est: -$0.89 | -1.1% | $67.0KEst: $150.0K | -55.3% | 10-K/A |
| Nov 13, 2024 | Q3 2024 | -$1.10Est: -$1.13 | +2.7% | $68.0KEst: $70.0K | -2.9% | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$1.03Est: -$1.50 | +31.3% | -Est: $10.0K | -100.0% | 10-Q |
| May 14, 2024 | Q1 2024 | -$4.75Est: -$3.75 | -26.7% | -Est: $150.0K | -100.0% | 10-Q |
| Apr 16, 2024 | Q4 2023 | -$4.75Est: -$3.25 | -46.2% | - | — | 10-K/A |
| Nov 14, 2023 | Q3 2023 | -$9.25Est: -$6.25 | -48.0% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$6.25Est: -$6.25 | 0.0% | - | — | — |
| May 15, 2023 | Q1 2023 | -$10.00 | — | - | — | — |